According to the National Institute for Cannabis Investors, 2019 is turning into the best year yet for CBD companies, and today we're bringing you the three best CBD stocks to buy now.
In fact, the CBD market is set to grow by over 3,000% in the next three years.
Cronos Group Inc
These Are the 3 Best CBD Stocks to Buy Now
One of our best CBD stocks to buy now is poised to gain 172% over the next year.
And that’s because the CBD industry is about to explode.
In fact, it’s expecting 3,623% growth in just under three years.
The CBD market is already valued at $591 million since being legalized in the United States in December 2018.
But the Brightfield Group says this figure will soar to $22 billion by 2022.
This type of explosive growth is precisely why we’re so bullish on CBD stocks and the cannabis sector as a whole.
22 Billion Reasons to Buy These 3 CBD Stocks Today
The CBD industry has been booming in 2019. Yet, it’s far from over.
In fact, it’s expected to rocket another 3,623% over the next three years.
And that’s why Money Morning is bringing you the best CBD stocks to buy today…
These Charts Reveal the "Perfect Price" for These Big Pot Stocks
Technical analysis is the study of human psychology, which is represented in the form of price action on a chart. You analyze the stock itself.
Technical analysts look for repeatable patterns and indications that can predict future price movements. Since human psychology and emotions will always be a factor in stock markets, the study of historical price movements of a stock relays the fear and greed associated with that stock.
Let's look at two technical tools that I use often – which is to say, every day the markets are open.
The first shows the movement of price in a group of stocks relative to each other. The second is a broadly watched tool that shows us both the long-term trend of a stock and important areas of support and resistance.
Our Top Pot Stock to Buy Could Easily Double Your Money
It's been an incredible run for pot stocks over the last three years. A $10,000 investment in Aurora Cannabis Inc. (NYSE: ACB) in early 2016 would have handed you more than $200,000. And $10,000 invested in Cronos Group Inc. (NASDAQ: CRON) during that same time would have netted you over $760,000. That is the power […]
This is the best pot stock to buy today...
Dow Jones Industrial Average Up Early Today After State of the Union Address
Start the conversation
You must be logged in to post a comment.
The Dow Jones Industrial Average was up slightly this morning as investors react to President Trump’s State of the Union Address.
Another busy day of earnings reports will see investors pouring through results and conference calls looking for guidance for the market in 2019. In addition, Federal Reserve Chair Jerome Powell will speak in Washington this evening.
Here are the numbers from Tuesday for the Dow, S&P 500, and Nasdaq...
Marijuana Mergers and Acquisitions Could Unleash Triple-Digit Returns
Marijuana mergers and acquisitions are going to be the talk of Wall Street in 2019.
It's going to lead to a new wave of wealth.
And this is how you can make a triple-digit profit...
Here's What You Need to Know About Marijuana Mergers
We've seen time and again how "takeover targets" provide the opportunity for truly explosive gains. The right company finds the right buyer, and investors gleefully strap in for a virtually instantaneous double- or triple-digit ride.
Dealmaking in general has done some "exploding" of its own over the past few years. 2018 broke records, with some $3.3 trillion worth of dried ink in place by September. That figure was bolstered by the advent of so-called "megadeals" worth more than $5 billion.
Companies have finally figured out the mother of all corporate no-brainers: If you can't beat 'em… buy 'em.
They've realized there's no point in throwing millions (or billions) of your – scratch that, your shareholders' – dollars at a thorny R&D, tech, or PR problem when you can just ride out, find some smaller company that's already done the work, and… acquire, acquire, acquire.
So, when we come across a frenzy of M&A activity in an already rapidly growing, high-profit sector like legal cannabis, it pays to stop and take a good hard look at what's happening.
Let's take a look at how powerful a moneymaker marijuana deals could be next year...
The Aphria Bear Raid Is a Gift in Disguise for Weed Investors
In a blistering month for stocks, Aphria has had a particularly bumpy ride.
The Leamington, Canada-based cannabis company was the target of some explosive (and, as we'll see, spurious) allegations from, as it turns out, a firm with substantial short interest. This is a common enough occurrence in the stock market, as Carl Icahn and Bill Ackman's legendary "long vs. short" battle royale over Herbalife Nutrition illustrates.
The short-seller's allegations focus only on Aphria and one other, small company: Toronto, Ont.-based SOL Global Investments. They have nothing to do with other cannabis firms we follow at the National Institute for Cannabis Investors
But, since the short attack and furious price action last week, I wanted everyone to know what's really happening with Aphria.
Dow Jones Industrial Average Climbs Despite U.S. Companies Adding Fewer Jobs
Start the conversation
You must be logged in to post a comment.
The Dow Jones Industrial Average projected a small gain in premarket hours as investors awaited the arrival of the November jobs report.
This morning, the Department of Labor said that the U.S unemployment remained at a 49-year low.
Start the conversation